If ultimately approved, the drug, aducanumab, made by Biogen, would be the first new Alzheimer’s treatment in nearly two decades. Some evidence suggests it slows, but does not stop, cognitive decline.. via NYT Health https://ift.tt/3jZ7hgp

Products You May Like

Articles You May Like

This Body-Positive TikToker Wants You to Know You’re Worthy at Every Size
Fashion Blogs Died, But Fashion Newsletters Are Filling the Void
The 5 Beauty Products ELLE Editors are Obsessed with This Week
Chanel’s New Campaign Celebrates an Icon
Simone Biles Wants People to Acknowledge Women as Greatest Athletes of All Time — and She Is One

Leave a Reply

Your email address will not be published. Required fields are marked *